Using a mathematical model that links seasonal patterns of antibiotic use with resistance, researchers from Harvard and the Centers for Disease Control and Prevention (CDC) have found that seasonal changes in population-wide macrolide use is associated with a small rise in azithromycin non-susceptibility in Neisseria gonorrhoeae isolates.
The Coalition for Epidemic Preparedness Innovations (CEPI) recently announced a collaboration with Germany-based IDT Biologika worth up to $36 million to develop and produce a vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV).
A new study in the Journal of Antimicrobial Chemotherapy shows that Internet-based communication training might be a cost-effective way to limit primary care antibiotic prescriptions when compared with C-reactive protein (CRP) testing.
The US Food and Drug Administration (FDA) reported yesterday that French diagnostics firm bioMerieux has recalled two of its antimicrobial susceptibility testing (AST) cards because of false results for some strains of methicillin-resistant Staphylococcus aureus (MRSA).
Finnish researchers are reporting the first transmission of carbapenemase-producing Escherichia coli between humans and dogs.
Fully 41% of antibiotic prescriptions written for patients with ARIs were inappropriate.
The study found no signifiant difference in patients with lower respiratory tract infections.
The federal government needs to develop better vaccine production capacity, support strong global security, and bolster nationwide public health to be better prepared for the next pandemic, a high-level tabletop exercise yesterday sponsored by the Johns Hopkins Center for Health Security found.
The list offers a way of focusing limited resources toward diagnosing the most common conditions as well as priority diseases.
CARB-X is adding another diagnostic system to its growing portfolio of products targeting drug-resistant bacteria.